Egyptian International Pharmaceutical Industries Co
Clinical trials sponsored by Egyptian International Pharmaceutical Industries Co, explained in plain language.
Egyptian pharmaceutical manufacturer producing generic and branded medicines.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New vitamin b shot with energy booster aims to soothe diabetic nerve pain
Symptom relief Not yet recruitingThis study tests an injectable supplement that combines B vitamins with an energy molecule (ATP) to treat painful diabetic nerve damage. Two hundred adults with diabetes and nerve pain will receive either the ATP-enhanced shot or a standard B vitamin shot for 12 weeks. Researcher…
Phase: PHASE4 • Sponsor: Egyptian International Pharmaceutical Industries Co • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
New generic blood thinner put to the test in healthy volunteers
Knowledge-focused Not yet recruitingThis study checks if a new generic version of the blood thinner enoxaparin works the same as the brand-name drug Clexane. About 26 healthy adults will receive a single dose of each drug, one week apart, and have their blood tested. The goal is to see if the generic is a safe and …
Phase: PHASE1 • Sponsor: Egyptian International Pharmaceutical Industries Co • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC